Akron Bio logo — Powering the future of medicine

Akron Bio

Powering the future of medicine

Founded 2006 United States Boca Raton, United States 113 employees Biotechnology, Health Care +1

General Information

Company Name Akron Bio
Founded Year 2006
Location United States Boca Raton, United States +2
Employees 113
Industries Biotechnology, Health Care, Manufacturing
Social

Get notified when Akron Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Akron Bio

Akron Bio is a biotechnology, health care, and manufacturing company founded in 2006 in the United States. The company is dedicated to powering the future of medicine by providing GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Since its inception, Akron has been a key player in the biotechnology and healthcare industries. The company specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies, in addition to offering a line of GMP quality cytokines, growth factors, blood-derived products, and custom media. Notably, Akron's newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards, ensuring the production of high-quality products adhering to regulatory requirements. Akron positions itself as a strategic partner for advanced therapy developers, providing the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to commercialization. As of the latest available information, Akron Bio has not disclosed its last investment details or the involved investors. This indicates that the company may be open to potential investment opportunities or funding rounds in the future.

Taxonomy: regenerative medicine, GMP compliance, advanced therapies, cell and gene therapy, manufacturing facility, clinical trial support, FDA compliance, custom plasmids, gene editing technologies, tissue engineering, cryopreservation media, stem cell products, recombinant proteins, commercialization support

No funding data available for Akron Bio yet.

Get notified when Akron Bio raises funding

Akron Bio Alternatives & Competitors

Akron Bio vs

An integrated cell and gene therapy Contract Testing, Development and Manufacturing Organization (CT...

412 employees
Biotechnology, Life Sciences
Akron Bio vs
AcceGen
AcceGen United States

AcceGen - Your Expert on Cells

14 employees
Biotechnology, Pharmaceutical
Akron Bio vs
ExcellGene SA
ExcellGene SA Switzerland

We are a CDMO providing Swiss quality cell line development and protein expression services. Expect...

Unknown
66 employees
Biotechnology, Information Technology

FAQ About Akron Bio

Powering the future of medicine
Akron Bio was founded in 2006.
Akron Bio is headquartered in Boca Raton, United States.
Akron Bio operates in the following industries: Biotechnology, Health Care, Manufacturing.
Akron Bio has approximately 113 employees.
Top alternatives and competitors to Akron Bio include WuXi Advanced Therapies, AcceGen, ExcellGene SA, Hopstem Biotechnology Co., Ltd., Batavia Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Akron Bio and WuXi Advanced Therapies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Akron Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy